The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy and Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Mar 2023)
Editorial: Liver diseases and programmed cell death
Peng Cao,
Yongyi Liang,
Yi Wang,
Chao Mao,
Weijia Wang,
Sha Li,
Lianxiang Luo
Affiliations
Peng Cao
Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Yongyi Liang
The First Clinical College, Guangdong Medical University, Zhanjiang, China
Yi Wang
Department of Critical Care Medicine, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Chengdu, China
Chao Mao
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Weijia Wang
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian, China
Sha Li
School of Public Health, Shanghai Jiao Tong University, Shanghai, China
Lianxiang Luo
The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China
DOI
https://doi.org/10.3389/fphar.2023.1182013
Journal volume & issue
Vol. 14
Abstract
Read online
No abstracts available.
Keywords
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
alcohol-related liver disease
drug induced liver injury
hepatocellular carcinoma
programmed cell death
WeChat QR code
Close